HII — Huntington Ingalls Industries, Inc.

Price action, not fundamentals, is driving sentiment as of 2026-09-13. HII is -32.7% over six months, -14.4% over the past month and -2.2% over the past week, meaning the decline actually re-accelerated after the late-July Q2 print. The shares are 5.6% below the 20-day and 6.0% below the 50-day SMA, and 19.5% below the 200-day, versus a 52-week range of $263.62-$460 (the March 2026 peak is now 39% above the current price). The counter-evidence is real but has not yet been rewarded: Q2 2026 revenue rose 10.9% YoY to $3.4B, diluted EPS hit $5.27 versus roughly $3.82 consensus, segment operating income expanded 30.2%, and management lifted shipbuilding revenue guidance by $500M and raised the operating-margin floor to 6.0-6.5%. Wall Street's response has been lukewarm - the FMP rating mix is 11 buy / 15 hold / 1 sell with a 'Hold' consensus label and only three analysts publishing targets (consensus $333). The market is debating whether HII's throughput initiatives convert into cash, not whether the backlog exists.

The top line clearly inflected. Revenue went from -2.4% YoY in Q3 2024 and -5.4% YoY in Q4 2024 to +3.5% in Q2 2025, +16.1% in Q3 2025, +15.7% in Q4 2025, +13.4% in Q1 2026 and +10.9% in Q2 2026 - a genuine trend change, not a one-quarter blip, though growth is now decelerating off the Q3 2025 peak. Operating margin tells a trough-and-recovery story: it collapsed to 2.98% in Q3 2024 and 3.66% in Q4 2024 (versus 9.82% in Q4 2023) on fixed-price contract charges, then recovered through 5.89% (Q1 2025), ~5.0% (Q2/Q3 2025), 4.52% (Q4 2025), 5.00% (Q1 2026) to 6.14% in Q2 2026 - the best level since Q4 2023. EPS tracks that: $2.56 in Q3 2024 to $5.27 in Q2 2026, up 36.5% YoY and the highest quarterly figure since Q4 2023's $6.90. The offset is gross margin, which has structurally compressed from ~15.5% in Q4 2023 to 13.2% in Q2 2026 as revenue mix shifted and volume rose. The genuinely weak leg is cash: free cash flow was -$464M in Q1 2026 and -$105M in Q2 2026 (-$569M for H1) versus +$265M in H1 2025, and Q2 2026's -$105M compares badly to Q2 2025's +$727M. Cash fell to $12M at 2026-06-30 from $774M at 2025-12-31. Verdict: an earnings and margin inflection in progress, financed for now off the balance sheet, with cash conversion as the unresolved swing factor.

Fair, leaning slightly cheap - not a screaming value. As of 2026-09-13 the trailing P/E of 16.65x sits essentially on top of the 5-year average of 16.13x, and P/S of 0.836 is a hair below the 5-year average of 0.86 - which is precisely why the deterministic overlay labels valuation 'Neutral vs. its own history.' On forward numbers the picture is better: $279.69 against consensus EPS of $18.66 is ~15.0x, versus 24.7x on the same estimate at the March 2026 peak of $460. The PEG of 0.647 looks cheap, but treat it with suspicion - the 'growth' is partly cyclical recovery off a 2024 margin trough, not a durable 15%+ compounding rate. The bear case on multiple: 5.0% net margin, 9.0% ROIC versus a cost of capital probably in the 8-9% range, negative H1 free cash flow, and $2.7B of long-term debt against $12M of cash all argue HII deserves a discount to LMT/NOC/GD. The bull case: a multi-year Navy backlog, raised guidance, and a 1.876% dividend yield. Net, roughly 15-16x forward earnings is the right neighbourhood for this business.

The key fact is that estimates went up while the price went down. Q2 2026 EPS of $5.27 beat the ~$3.82 consensus by ~38%, and management raised FY shipbuilding revenue guidance by $500M and lifted the operating-margin floor to 6.0-6.5%. Yet the stock is -14.4% over the past month. Re-rating from ~25x to ~15x forward explains the entire $460-to-$280 move - so the market is not pricing in an earnings miss, it is pricing in execution and cash-conversion doubt (H1 2026 FCF of -$569M, cash down to $12M). That is the swing variable: HII's cash flow is heavily seasonal, with Q1 the burn quarter (-$462M in Q1 2025, -$277M in Q1 2024) and Q4 the inflow quarter (+$516M in Q4 2025, +$277M in Q4 2024), so H2 2026 will decide whether the negative H1 was timing or a problem. If H2 converts and guidance holds at the Q3 print in late October/early November 2026, a 15x forward multiple on rising estimates has room to normalise toward 16-17x. If H2 cash flow disappoints again, the stock is a value trap and 15x on earnings that aren't converting to cash is not cheap at all.

Unambiguously a downtrend, and not yet oversold enough to call a bottom. As of 2026-09-13, RSI(14) stood at 34.16 - weak, but above the 30 oversold threshold - with price -5.63% versus the 20-day SMA, -6.00% versus the 50-day and -19.50% versus the 200-day. The 52-week range is $263.62-$460 and the $279.69 price is only ~6% above the low, so support is close and thin. Returns confirm persistent selling pressure: -2.18% over one week, -14.42% over one month, -6.04% over three months and -32.72% over six months - the one-month figure being worse than the three-month figure shows the decline re-accelerated recently rather than basing. There is no technical reversal signal here: no RSI divergence, no reclaim of the 20-day, no higher low. Entry-timing implication: this is a falling knife; a patient buyer would want either an RSI print below 30 with a reversal candle, or a clean reclaim of the 50-day (~$298 area) before treating the level as a floor. Note the reported beta of 0.225 is almost certainly a stale artefact given the stock lost a third of its value in six months.

• Defense budget and geopolitics: heightened U.S.-Iran tensions and oil above $100/barrel reinforce structural demand for naval power and fleet expansion, which underpins HII's multi-year carrier and submarine backlog - a genuine tailwind that operates on a multi-year, not quarterly, timescale.
• Interest rates: elevated rates raise the discount applied to long-duration defense cash flows and increase the cost of the ~$2.7B of long-term debt HII carries, a modest structural headwind for a capital-intensive prime.
• Sector rotation and risk-off: broad industrial/defense equity rotation away from cyclicals has compressed HII's multiple even as earnings estimates rose, decoupling price from fundamentals.
• Supply chain and labor: persistent inflation, skilled-trades shortages, collective bargaining agreements extended through 2031 at Ingalls, and HII's plan to outsource over 2 million work hours to relieve single-yard bottlenecks - all of which carry execution and cost risk.
• Shipyard capacity and industrial-base constraints: the U.S. Navy's own ability to fund, schedule and absorb new hulls (CVN-82 keel laying now targeted for 2027) sets a ceiling on how quickly HII can convert backlog into revenue and cash.

• Q3 2026 earnings, tentatively late October/early November 2026 - the single most important near-term event, testing whether the raised 6.0-6.5% operating-margin guidance and $500M revenue raise are maintained, and whether H2 free cash flow reverses the -$569M H1 burn.
• Carrier and submarine program milestones - further CVN-82 (USS William J. Clinton) awards after the $336.1M September 2026 long-lead contract, Block VI Virginia-class and Block II Columbia-class execution, each a potential de-risking or de-risking-busting data point.
• Proof points on the throughput plan - HII has targeted ~15% shipyard throughput improvement in 2026 via outsourcing and AI-enabled production; evidence it is landing would directly address the margin and cash-conversion bear case.
• FY2027 defense appropriations and any supplemental naval funding, which would extend backlog visibility beyond the current program set.
• Dividend and capital-return sustainability - with $12M of cash at 2026-06-30 against a ~$207M annual dividend (1.876% yield), any change in capital-return policy would be a meaningful signal.

• Cash conversion is the dominant risk: H1 2026 free cash flow of -$569M versus +$265M in H1 2025, Q2 2026 FCF of -$105M versus +$727M a year earlier, and cash collapsing to $12M from $774M in six months. A repeat in H2 would call the earnings quality and the dividend into question.
• Structurally thin margins: 5.0% net margin, 5.2% operating margin and 12.6% gross margin TTM leave almost no cushion, so a single fixed-price contract charge can swing quarterly EPS by 30%+ as it did in Q3-Q4 2024.
• Gross margin compression from ~15.5% in Q4 2023 to 13.2% in Q2 2026 - revenue is growing on lower-margin mix, so top-line strength does not translate proportionally into profit.
• Balance sheet leanness: $2.7B long-term debt against $12M cash, current ratio of 1.23, and a 1.88% positive accruals ratio (net income running ahead of operating cash flow) - a caution flag on reported earnings quality.
• ROIC of 9.0% versus ROE of 11.9% suggests returns are only marginally above the cost of capital, limiting the case for a premium multiple.
• Execution risk on the throughput/outsourcing plan and persistent labor and supplier constraints at single-yard sites such as Newport News, which could delay revenue recognition or add cost.
• Technical and sentiment risk: the stock is in a confirmed downtrend with no reversal signal, and a break below the $263.62 52-week low could invite further momentum-driven selling.

HII is a genuinely improving business with a badly damaged stock price, and the honest read is that the improvement has not yet been proven where it matters - cash. Revenue growth re-accelerated to double digits, Q2 2026 EPS of $5.27 beat by ~38%, guidance was raised, and the multi-year Navy backlog is as visible as it gets. But H1 2026 free cash flow of -$569M, cash down to $12M from $774M, a 5.0% net margin and 9.0% ROIC mean you are paying 15x forward earnings for a business that is not currently converting profit into cash, while the stock sits in a confirmed downtrend with no technical floor. This is a wait-for-proof situation, not a buy-the-dip - I would want to see H2 2026 cash conversion and the Q3 guidance reaffirmation before committing, which puts me closer to bearish than bullish at $279.69. If H2 converts cleanly, the 15x forward multiple has real room to normalise and the March 2026 de-rating will look overdone; if it does not, this is a value trap.

I applied a 16.0x forward P/E - essentially in line with HII's own 5-year average TTM P/E of 16.13x, and a modest discount to large-cap defense primes - to the consensus forward EPS of $18.66, giving $298.56, rounded to $299. The multiple is deliberately held at (not above) the historical average because HII's 5.0% net margin, 9.0% ROIC and negative H1 2026 free cash flow argue against a premium, while the raised 6.0-6.5% margin guidance and visible backlog argue against a discount; a cross-check on 12x forward EV/EBITDA (~$1.23B EBITDA on $13.4B guided revenue against a $13.7B enterprise value) lands at roughly $306, confirming the $299 figure is not an outlier. This sits below the FMP analyst consensus target of $333, reflecting my view that the market will not re-rate the multiple until cash conversion is demonstrated.